NCT05785039View on ClinicalTrials.gov

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Locally Advanced or Metastatic Urinary System Tumors

PHASE2RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Urinary System TumorSolid Tumor
Interventions
DRUG

BL-B01D1

Administration by intravenous infusion

Trial Locations (1)

200032

RECRUITING

Fudan University ShangHai Cancer Center, Shanghai

All Listed Sponsors
collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY